News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
639,857 Results
Type
Article (61400)
Company Profile (124)
Press Release (578333)
Section
Business (175969)
Career Advice (2721)
Deals (32789)
Drug Delivery (87)
Drug Development (77333)
Employer Resources (149)
FDA (14988)
Job Trends (14053)
News (308502)
Policy (29461)
Tag
Academia (2889)
Alliances (43567)
Alzheimer's disease (1165)
Approvals (14918)
Artificial intelligence (118)
Bankruptcy (288)
Best Places to Work (10793)
Biotechnology (88)
Breast cancer (104)
Cancer (888)
Career advice (2304)
Cell therapy (207)
Clinical research (61021)
Collaboration (315)
Compensation (98)
COVID-19 (2546)
C-suite (83)
Data (848)
Diabetes (123)
Diagnostics (5933)
Drug pricing (78)
Earnings (59093)
Employer resources (132)
Events (93342)
Executive appointments (255)
FDA (15427)
Funding (279)
Gene therapy (146)
GLP-1 (533)
Government (4426)
Healthcare (18342)
Infectious disease (2612)
Inflammatory bowel disease (101)
Interviews (523)
IPO (14777)
Job creations (3533)
Job search strategy (1945)
Layoffs (441)
Legal (6680)
Lung cancer (147)
Manufacturing (142)
Medical device (12520)
Medtech (12525)
Mergers & acquisitions (18077)
Metabolic disorders (333)
Neuroscience (1395)
NextGen Class of 2024 (6562)
Non-profit (4423)
Northern California (1114)
Obesity (191)
Opinion (201)
Patents (92)
People (58593)
Phase I (19110)
Phase II (26895)
Phase III (19735)
Pipeline (202)
Postmarket research (2498)
Preclinical (8175)
Radiopharmaceuticals (238)
Rare diseases (179)
Real estate (6091)
Regulatory (19535)
Research institute (2412)
Resumes & cover letters (406)
Southern California (980)
Startups (3369)
United States (10593)
Vaccines (530)
Weight loss (142)
Date
Today (208)
Last 7 days (781)
Last 30 days (2770)
Last 365 days (32954)
2024 (28025)
2023 (36765)
2022 (47222)
2021 (52152)
2020 (51304)
2019 (45335)
2018 (34568)
2017 (31052)
2016 (30507)
2015 (35892)
2014 (28824)
2013 (25425)
2012 (26762)
2011 (27008)
2010 (25445)
Location
Africa (945)
Arizona (138)
Asia (38286)
Australia (6813)
California (2466)
Canada (1072)
China (192)
Colorado (111)
Connecticut (113)
Europe (87313)
Florida (376)
Georgia (98)
Illinois (318)
Indiana (158)
Kansas (88)
Maryland (470)
Massachusetts (1863)
Michigan (144)
Minnesota (209)
New Jersey (777)
New York (753)
North Carolina (682)
Northern California (1114)
Ohio (118)
Pennsylvania (654)
South America (1209)
Southern California (980)
Texas (353)
Utah (79)
Washington State (298)
639,857 Results for "university of south florida".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tevogen Bio’s Innovation and Public Health Advisory Board Chairperson, Professor Sten Vermund, Appointed Dean of the University of South Florida Health College of Public Health
August 14, 2024
·
2 min read
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
Vaxxinity, Inc. today announced a research collaboration with the University of Florida’s (UF) Center for Translational Research in Neurodegenerative Disease (CTRND) to support its work on the development of vaccines for neurodegenerative diseases.
January 30, 2024
·
6 min read
BioMidwest
Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
Vaxxinity, Inc., a U.S. company pioneering the development of a new class of medicines, announced a collaboration with the University of Central Florida to advance space medicine research.
January 18, 2024
·
6 min read
Deals
Solis Mammography Announces Acquisition of MUSIC Imaging Center in Gainesville, Florida
Solis Mammography, a premier women’s health company and the nation’s largest independent provider of specialized breast health services, has announced the acquisition of MUSIC Mammography and Ultrasound Imaging Center in Gainesville, Florida.
May 28, 2024
·
2 min read
Press Releases
Solis Mammography Announces Acquisition of Breast Center of Acadiana in South Louisiana
October 10, 2024
·
2 min read
Research Park at Florida Atlantic University® Announces Headquarters of Surgical Instrument Sterilization Leader
The Research Park at Florida Atlantic University® is pleased to announce that Instrumentum, an emerging leader in the surgical instrument sterilization field has located its headquarters in the Research Park at Florida Atlantic University®
October 12, 2023
·
4 min read
Press Releases
The Medical University of South Carolina Becomes First in South Carolina to Adopt MOLLI Surgical’s Advanced Breast Cancer Technology
July 25, 2024
·
4 min read
Biotech Bay
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor
Astellas Pharma Inc. announced the opening of a new $90 million, state-of-the-art center at 480 Forbes Boulevard in South San Francisco, CA.
May 8, 2024
·
3 min read
Business
Parse Biosciences Announces Partnership with Gencell Pharma to Extend its Reach in South America
Parse Biosciences today announced an agreement with Bogotá, Colombia-based Gencell Pharma to extend Parse’s reach in Colombia specifically and also across South America.
June 25, 2024
·
2 min read
Antengene Announces XPOVIO® (selinexor) National Health Insurance Service Approval for Reimbursement in South Korea
Antengene Corporation Limited announced that South Korea’s National Health Insurance Service has approved the reimbursement of XPOVIO® for the treatment of adult patients with relapsed or refractory multiple myeloma.
June 26, 2024
·
5 min read
1 of 63,986
Next
